Exploring the role of epigenetics in the processes related to the development of endometrosis in the mare.

Overview

• This research article reviews the role of epigenetic mechanisms in the development and progression of endometrosis, a chronic uterine fibrosis condition in mares.
• It focuses on how DNA methylation, non-coding RNAs, and histone modifications regulate gene networks involved in fibrosis and inflammation, with implications for diagnosis and therapy.

Introduction to Endometrosis

• Endometrosis is a chronic degenerative disease affecting the endometrium (uterine lining) in mares.
• Characterized by progressive fibrosis (excessive deposition of fibrous connective tissue) and changes in glandular structures.
• These pathological changes impair uterine function, disrupt normal glandular secretions, and compromise fertility and pregnancy maintenance.
• Underlying causes include persistent inflammation and activation of myofibroblasts—cells responsible for ECM production.
• Accumulation of extracellular matrix (ECM) components interferes with normal tissue architecture and function.

Current Understanding of Pathogenesis

• Histopathological studies have thoroughly described the tissue-level changes seen in endometrosis.
• However, molecular and cellular pathways driving the disease are not yet fully understood.
• Understanding these pathways is crucial for developing better diagnostics and therapies.

Role of Epigenetics in Endometrosis

• Epigenetics refers to heritable changes in gene expression that do not involve changes to the DNA sequence.
• Key epigenetic mechanisms implicated in fibrosis include:
• DNA methylation: Addition of methyl groups to DNA, often silencing gene expression.
• Non-coding RNAs (ncRNAs): RNA molecules that do not code for proteins but regulate gene expression post-transcriptionally.
• Histone modifications: Chemical changes to histone proteins around which DNA is wrapped, affecting chromatin structure and gene accessibility.
• These mechanisms dynamically regulate genes involved in fibrosis, inflammation, and ECM turnover.

DNA Methylation in Endometrosis

• Altered patterns of DNA methylation are observed in key profibrotic and antifibrotic genes.
• Hypermethylation (increased methylation) can silence antifibrotic genes leading to excessive ECM accumulation.
• Hypomethylation (decreased methylation) of profibrotic genes may increase collagen deposition and activate myofibroblasts.
• These changes contribute to the balance of ECM synthesis and degradation being disrupted.

Non-Coding RNAs in Fibrosis Regulation

• Specific ncRNAs regulate gene expression related to fibrosis and inflammation pathways.
• For example, some microRNAs (miRNAs) can suppress antifibrotic genes or enhance profibrotic signaling.
• Altered expression of long non-coding RNAs (lncRNAs) can also influence myofibroblast activation and ECM production.
• ncRNAs serve as fine-tuners of gene networks involved in endometrosis.

Histone Modifications and Chromatin Remodeling

• Changes in histone acetylation and methylation modulate chromatin structure, affecting gene accessibility.
• In fibrotic tissues, specific histone modification patterns are linked to the upregulation of fibrosis-related genes.
• These modifications may promote persistent expression of genes driving fibrosis and inflammation.

Dynamic Epigenetic Changes in Endometrium and Myometrium

• Recent studies indicate that both the endometrial and myometrial tissues undergo epigenetic alterations during endometrosis progression.
• These changes impact cell behavior, including myofibroblast activation and ECM deposition.
• Understanding tissue-specific epigenetic signatures could enhance detection and targeted treatment approaches.

Implications for Diagnosis and Treatment

• Epigenetic markers may serve as novel biomarkers for early detection and monitoring of endometrosis in mares.
• Therapeutic strategies could aim to reverse harmful epigenetic changes, for example, using drugs that modulate DNA methylation or histone modifications.
• ncRNA-based therapies might target key regulatory RNAs involved in fibrosis pathways.
• Improved molecular insights could lead to better fertility management and reproductive outcomes in affected mares.

Summary

• This review consolidates current evidence linking epigenetic regulation to the development and progression of endometrosis in mares.
• It highlights DNA methylation, ncRNA expression, and histone modification as key mechanisms controlling fibrosis-related gene networks.
• Understanding these molecular underpinnings is essential for developing new diagnostic tools and targeted therapies to combat this common equine reproductive disorder.